Normal breast epithelial cells induce p53-dependent apoptosis and p53-independent cell cycle arrest of breast cancer cells

Breast Cancer Research and Treatment

Volumn 71, Issue 3, 2002, Pages 269-280

  Toillon, Robert Alain ^a   Chopin, Valérie ^a   Jouy, Nathalie ^b   Fauquette, William ^a   Boilly, Bénoni ^a   Bourhis, Xuefen Le ^a  

^a UNIV LILLE   (France)

^b Institut de Recherche sur le Cancer de Lille   (France)

Author keywords

Apoptosis; Breast cancer; Cell growth; Normal breast epithelial cells; p53; Tyrosine phosphatases

Indexed keywords

AGAR; COLLAGEN GEL; INHIBITOR PROTEIN; ORTHOVANADIC ACID; PIFITHRIN ALPHA; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CELL; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL CYCLE G1 PHASE; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

APOPTOSIS; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CELL CYCLE; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036207910     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014422101452     Document Type: Article

References (38)

1. New directions in breast cancer research
2. Growth factors, apoptosis, and survival of mammary epithelial cells
3. Autocrine and paracrine growth inhibitors of breast cancer cells
4. Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture
5. p53 in signalling checkpoint arrest or apoptosis
6. The cellular response to p53: The decision between life and death
7. Role of p53 members family members in apoptosis
8. p53 mutations in breast cancer: Incidence and relations to tumor aggressiveness and evolution of the disease
9. The molecular epidemiology of p53 gene mutations in human breast cancer
10. Tp53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc-binding domains
11. Regulation of neuronal survival by the serine-threonine protein kinase Akt
12. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
13. Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2
14. Signal transduction by c-jun N-terminal kinase (JNK)-from inflammation development
15. Mdm2 association with p53 targets its ubiquitination
16. Inhibition of tyrosine phosphatases antogonizes CD95-mediated apoptosis
17. Association of protein-tyrosine phosphatase PTP-BAS with the transcription-factor-inhibitory protein IkappaBalpha through interaction between the PDZ1 domain and ankyrin repeats
18. Induction of p53 dependent apoptosis upon overexpression of a nuclear protein tyrosine phosphatase
19. Identification of IkappaBalpha as a substrate of Fas-associated phosphatase-1
20. No evidence for involvement of mouse protein-tyrosine phosphatase-BAS-like Fas-associated phosphatase-1 in Fas-mediated apoptosis
21. Antisense p53 provokes changes in Hela cell growth and morphology
22. Characterization of morphogenetic and invasive abilities of human mammary epithelial cells: Correlation with variations of urokinase-type plasminogen activator activity and type-1 plasminogen activator inhibitor level
23. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy
24. Normal breast epithelial cells induce apoptosis of MCF-7 breast cancer cells through a p53-mediated pathway
25. The human myoepithelial cell is a natural tumor suppressor
26. The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis
27. Myoepithelial-specific CD-44 shedding contributes to the anti-invasive antiangiogenic phenotype of myoepithelial cells
28. Production and oestrogen regulation of FGFI in normal and cancer breast cells
29. Constitutive activation of NF-kappaB during progression of breast cancer to hormono-independent growth
30. Mechanism of regulation of WAF1/Cip 1 gene expression in human breast carcinoma: Role of p53-dependent and independent signal transduction pathways
31. Protein tyrosine phosphatase regulation of endothelial cell apoptosis and differentiation
32. Apoptosis in hematopoietic cells is associated with an extensive decrease in cellular phosphotyrosine content that can be inhibited by the tyrosine phosphatase antagonist pervanadate
33. Protein tyrosine phosphatase activities are involved in apoptotic cancer cell death induced by GL331, a new homolog of etoposide
34. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases
35. Characterization of the interactions between PDZ domains of the protein-tyrosine phosphatase PTPL1 and carboxyl-terminal tail of Fas
36. FAP-1: A protein tyrosine phosphatase that associates with Fas
37. Human pancreatic adenocarcinomas express Fas and Fas-ligand yet are resistant to Fas-mediated apoptosis
38. Overexpression of the transmembrane tyrosine phosphatase LAR activates the caspase pathway and induces apoptosis